Full Press Release Details
MORRISTOWN, N.J.,Nov. 26, 2025/PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq:WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer treatments, today announced that Dave Lennon, PhD, President and CEO, will participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference in New York City, NY on December 3, 2025, at 12:30 PM ET.
A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IRwebsiteand will be available for replay for approximately 30 days following the event.
About Whitehawk TherapeuticsWhitehawkTherapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments.Whitehawk'sadvanced three-assetADCportfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed fromWuXiBiologics under an exclusive development and global commercialization agreement. More information on the Company is available atwww.whitehawktx.comand connect with us on LinkedIn.
Contact:[email protected]
SOURCE Whitehawk Therapeutics, Inc.